InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Hill Stephen J.. Director active across 1 company, notably Lyell Immunopharma, Inc.. Aggregated, 2 reports have been published. History available since 9 February 2024. The latest transaction was disclosed on 10 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations